Kolexia
Cheuret Emmanuel Pédiatrie
Cheuret Emmanuel
Pédiatrie
Hôpital Paule de Viguier
Toulouse, France
53 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Encéphalite Sclérose en plaques Accident vasculaire cérébral Sclérose Syndrome de Guillain-Barré Névrite optique Encéphalite virale Grippe humaine Accident vasculaire cérébral ischémique

Collaborateurs

Voir plus
Deiva Kumaran
Deiva Kumaran
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Chaix Yves
Chaix Yves
Hôpital Paule de Viguier, Toulouse, France
Baudou Eloise
Baudou Eloise
Hôpital Purpan, Toulouse, France
Cances Claude
Cances Claude
Hôpital Paule de Viguier, Toulouse, France

Industries

Voir plus
Eisai
1 collaboration(s)
Dernière en 2020
Janssen
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
"Alternating" the Diagnosis after 40 Years of Disease: The Thousand Faces of ATP1A3 Mutation.
Movement disorders clinical practice   22 janvier 2024
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis: An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension
Essai Clinique (Biogen)   09 janvier 2024
IDAR: Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-myelin Oligodendrocytes Glycoprotein (Anti-MOG) Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   22 novembre 2023
Long-term outcomes of paediatric Guillain-Barré syndrome.
Developmental medicine and child neurology   27 juillet 2023
Cerebrospinal fluid YKL-40 level evolution is associated with autoimmune encephalitis remission.
Clinical & translational immunology   15 mars 2023
Le spectre des maladies à anticorps anti-MOG
HAS Publications   02 novembre 2022
Long-term outcome of paediatric anti-N-methyl-D-aspartate receptor encephalitis.
Developmental medicine and child neurology   05 octobre 2022
Post-CMV Guillain-Barré Syndrome with Anti-GM2 Antibodies: Two Cases and a Review of the Literature.
Neuropediatrics   18 juin 2022
Stiff Person Syndrome and Encephalitis with GAD Antibodies with Severe Anterograde Amnesia in an Adolescent: A Case Study and Literature Review.
Neuropediatrics   14 décembre 2021
Hemiplegic Migraine Associated With Variations: A Clinical and Genetic Study.
Neurology   14 octobre 2021